BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26862850)

  • 1. Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.
    Yuan L; Yi HM; Yi H; Qu JQ; Zhu JF; Li LN; Xiao T; Zheng Z; Lu SS; Xiao ZQ
    Oncotarget; 2016 Mar; 7(10):11463-77. PubMed ID: 26862850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling.
    Qu JQ; Yi HM; Ye X; Zhu JF; Yi H; Li LN; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Xiao ZQ
    Mol Cancer Ther; 2015 Nov; 14(11):2653-64. PubMed ID: 26304234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.
    Li LN; Xiao T; Yi HM; Zheng Z; Qu JQ; Huang W; Ye X; Yi H; Lu SS; Li XH; Xiao ZQ
    Mol Cancer Ther; 2017 Oct; 16(10):2094-2106. PubMed ID: 28698199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p.
    Huang W; Shi G; Yong Z; Li J; Qiu J; Cao Y; Zhao Y; Yuan L
    Cell Death Dis; 2020 Jul; 11(7):504. PubMed ID: 32632129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
    Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
    Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma.
    Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H
    Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy.
    Yi HM; Yi H; Zhu JF; Xiao T; Lu SS; Guan YJ; Xiao ZQ
    Tumour Biol; 2016 Mar; 37(3):2941-9. PubMed ID: 26409455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
    He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
    Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy.
    Ruan L; Wang GL; Yi H; Chen Y; Tang CE; Zhang PF; Li MY; Li C; Peng F; Li JL; Chen ZC; Xiao ZQ
    J Cell Biochem; 2010 Jul; 110(4):975-81. PubMed ID: 20564197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing fibronectin extra domain A enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK/Akt/JNK pathway.
    Ou J; Pan F; Geng P; Wei X; Xie G; Deng J; Pang X; Liang H
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e685-91. PubMed ID: 22208970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis.
    Chen Y; Ouyang GL; Yi H; Li MY; Zhang PF; Li C; Li JL; Liu YF; Chen ZC; Xiao ZQ
    J Proteome Res; 2008 Dec; 7(12):5254-62. PubMed ID: 19367706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-181a Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP.
    Huang W; Liu J; Hu S; Shi G; Yong Z; Li J; Qiu J; Cao Y; Yuan L
    Onco Targets Ther; 2019; 12():10873-10884. PubMed ID: 31849491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of annexin VII enhances nasopharyngeal carcinoma cell radiosensitivity in vivo and in vitro.
    Gui SJ; Ding RL; Wan YP; Zhou L; Chen XJ; Zeng GQ; He CZ
    Cancer Biomark; 2020; 28(2):129-139. PubMed ID: 31958076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation
    Chen J; Zhang F; Ren X; Wang Y; Huang W; Zhang J; Cui Y
    Cancer Biol Med; 2020 Aug; 17(3):740-752. PubMed ID: 32944403
    [No Abstract]   [Full Text] [Related]  

  • 17. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
    He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
    Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells.
    Wang M; Liu G; Shan GP; Wang BB
    Cancer Biother Radiopharm; 2017 Aug; 32(6):193-203. PubMed ID: 28820634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
    Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
    J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
    Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
    Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.